This article has been cited by
1Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides
Hsiang-Ting Ho,Bin Liu,Jedidiah S. Snyder,Qing Lou,Elizabeth A. Brundage,Florencia Velez-Cortes,Honglan Wang,Mark T. Ziolo,Mark E. Anderson,Chandan K. Sen,Xander H.T. Wehrens,Vadim V. Fedorov,Brandon J. Biesiadecki,Thomas J. Hund,Sándor Györke
Cardiovascular Research.2014;101(1)165
[DOI]
2Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides
Katarzyna Anna Mitrega,Magdalena Stankiewicz,Tadeusz F. Krzeminski
Cardiovascular Research.2014;36(1)257
[DOI]
3Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na+/K+-ATPase independent proteolysise
Cheng-Wei Yang,Hsing-Yu Hsu,Hsin-Yu Chang,Yue-Zhi Lee,Shiow-Ju Lee
Biochemical Pharmacology.2020;180(1)114122
[DOI]
4Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking
Guangping Liang,Tseyu Chung,Jinhua Guo,Rongrong Zhang,Wei Xü,Jason T. C. Tzen,Renwang Jiang
Chemical Research in Chinese Universities.2017;33(3)378
[DOI]
5Novel drug targets in clinical development for heart failure
Melvin George,Muthukumar Rajaram,Elangovan Shanmugam,Thangavel Mahalingam VijayaKumar
European Journal of Clinical Pharmacology.2014;70(7)765
[DOI]
6Novel drug targets in clinical development for heart failure
Patrick T. Campbell,Sepehr Saberian
European Journal of Clinical Pharmacology.2016;70(7)29
[DOI]
7Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies
Zijun Ge,Amy Li,James McNamara,Cris dos Remedios,Sean Lal
Heart Failure Reviews.2019;24(5)743
[DOI]
  Feedback 
  Subscribe